Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sildenafil Citrate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Aspargo Laboratories
Deal Size : Undisclosed
Deal Type : Acquisition
Aspargo Acquires Bandol Sildenafil Spray, Currently Marketed In Spain
Details : BANDOL®, offered in a convenient and discreet metered dose container that delivers the equivalent of 12.5 mg of Sildenafil per actuation, is manufactured in Spain and is prescribed predominantly by primary care physicians and urologists.
Brand Name : Bandol
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 04, 2022
Lead Product(s) : Sildenafil Citrate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Aspargo Laboratories
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?
Reset All
